Arbutus Biopharma Corporation · NASDAQ:ABUS
Arbutus Biopharma Corporation shareholders
As of Jun 30, 2026, 166 institutions reported holding Arbutus Biopharma Corporation, 71.1% of its shares. Largest: Two Seas Capital LP, Morgan Stanley and Whitefort Capital Management, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Arbutus Biopharma Corporation | Change | Filed |
|---|---|---|---|---|
| Two Seas Capital LP | 19.1M | 9.7% | +538K | Aug 12, 2026 |
| Morgan Stanley | 17.7M | 8.9% | −8.19M | Aug 13, 2026 |
| Whitefort Capital Management, LP | 15.8M | 8.0% | +863K | Aug 14, 2026 |
| BlackRock | 13.8M | 7.0% | +799K | Aug 7, 2026 |
| Vanguard | 9.87M | 5.0% | +544K | Aug 13, 2026 |
| State Street | 7.87M | 4.0% | +1.53M | Aug 7, 2026 |
| Rubric Capital Management LP | 7.53M | 3.8% | +907K | Aug 14, 2026 |
| Barclays | 4.21M | 2.1% | −108K | Aug 14, 2026 |
| Geode Capital | 4.12M | 2.1% | +346K | Aug 12, 2026 |
| Goldman Sachs | 3.51M | 1.8% | +2.41M | Aug 14, 2026 |